Literature DB >> 1856144

Once daily dosing of aminoglycoside: one step forward.

J C Pechère1, W A Craig, F Meunier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856144     DOI: 10.1093/jac/27.suppl_c.149

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing.

Authors:  P J Wood; L L Ioannides-Demos; E B Bastone; W J Spicer; A J McLean
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 2.  New respiratory therapies in cystic fibrosis.

Authors:  D E Stableforth
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

3.  Once daily dosing of netilmicin in neonatal and pediatric intensive care.

Authors:  B P Wagner; J Pfenninger
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

Review 4.  Aminoglycoside dosage regimens. Is once a day enough?

Authors:  W N Hustinx; I M Hoepelman
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

5.  Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.

Authors:  A Buxbaum; A Georgopoulos
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

6.  Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.

Authors:  P Vic; S Ategbo; D Turck; M O Husson; V Launay; G A Loeuille; A Sardet; A Deschildre; D Druon; C Arrouet-Lagande
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

7.  Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.

Authors:  M L Barclay; E J Begg; S T Chambers
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.